Thomas Strüngmann is a prominent German entrepreneur and investor, best known for his significant contributions to the pharmaceutical industry.
Thomas Strüngmann was born on February 9, 1950, in Germany. He grew up in a family with a strong business background, which influenced his future career in the pharmaceutical sector.
Thomas Strüngmann leads a relatively private life. He is known to be family-oriented and has a twin brother, Andreas Strüngmann, with whom he frequently collaborates in business ventures.
Thomas Strüngmann co-founded Hexal AG, a generic pharmaceutical company, which was later sold to Novartis. He is also known for his investments in healthcare and biotechnology, including a significant stake in BioNTech.
Thomas Strüngmann's notable achievements include the co-founding and successful sale of Hexal AG, as well as his investment in BioNTech, which developed one of the first COVID-19 vaccines.
Yes: 1090
No: 146
Explanation: Based on the current data, 1090 votes suggest that the person is Jewish, while 146 votes suggest they are not. Cast your vote to make a difference!
Don't miss out on voicing your opinion. Click below to cast your vote on whether Thomas Strungmann is Jewish.
Comments
Leave a Comment